Table 4.
Multivariate analysis for patients with BRAF mutated colorectal cancer.
| Characteristics | N | Overall survival | ||
|---|---|---|---|---|
| HR | 95% CI | P | ||
| Mutational status | ||||
| BRAF V600E | 54 | 1 | ||
| BRAF non-V600E | 20 | 0.34 | 0.14–0.84 | 0.019 |
| Age | ||||
| <49 year | 32 | 1 | ||
| ≥49 year | 42 | 1.98 | 0.87–4.48 | 0.102 |
| Gender | ||||
| Male | 45 | 1 | ||
| Female | 29 | 1.28 | 0.61–2.69 | 0.523 |
| Primary tumor site | ||||
| Right colon | 26 | 1 | ||
| Left colon/rectum | 48 | 1.38 | 0.61–3.12 | 0.436 |
| Stage | ||||
| I, II, III | 15 | 1 | ||
| IV | 59 | 1.75 | 0.73–4.21 | 0.212 |